Sign In
Buy WGS
$53.02
-0.110 (-0.207%)
At Close: Jun 03, 2026
GeneDx Holdings: A Phenomenal Comeback With More Room To Run
02:03am, Thursday, 16'th Jan 2025
GeneDx Holdings Corp. experienced a dramatic turnaround in 2024, achieving profitability and 100x returns, driven by reduced cash burn and strategic product innovations. Key growth catalysts include t
GeneDx Announces Preliminary 2024 Financial Results
08:30am, Monday, 13'th Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported preliminary financial results for the fourth quarter and full year of 2024.
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers
08:30am, Thursday, 09'th Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx launches new telehealth testing pathway to connect parents directly with genetic experts to increase access to exome and genome testing.
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients
08:30am, Wednesday, 08'th Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through und
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains?
06:21am, Tuesday, 07'th Jan 2025
GeneDx Holdings (WGS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly
09:15am, Saturday, 04'th Jan 2025
Meta Platforms leads five stocks flashing entries as they rebound above key moving averages within consolidations. The post Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly appeared fir
Best-Performing Stocks Of 2024
11:46pm, Thursday, 02'nd Jan 2025
Best-Performing Stocks Of 2024
GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer
04:01pm, Thursday, 02'nd Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Bryan Dechairo as Chief Operating O
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 16'th Dec 2024
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 43rd A
This Once Ultracheap Biotech Stock Rockets 2,762%, Nears Buy Point After Big Earnings Win
01:26pm, Monday, 25'th Nov 2024
Biotech stock GeneDx soared 50% after earnings on Oct. 29. Shares of the genetic testing company have soared 2,762% year to date.
GeneDx to Participate in Upcoming Investor Conference
04:05pm, Friday, 22'nd Nov 2024
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference.
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
08:30am, Monday, 18'th Nov 2024
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Heidi Chen as Chief Legal Officer,
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
04:54am, Saturday, 16'th Nov 2024
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
04:35pm, Thursday, 07'th Nov 2024
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the results of an extensive study shedding light on th
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
04:35pm, Monday, 04'th Nov 2024
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at the 2024 American Soci
